The Southern Africa Development Community Malaria Elimination Eight Initiative (SADC E8) is a regional collaboration established by SADC Ministers of Health in 2009. The E8 mandate is to coordinate and execute a regional malaria elimination strategy aimed at achieving the historic goal of eliminating malaria in southern Africa.
Due to the high degree of interconnectedness within the region, countries that have reduced malaria to low levels face the challenge of persistent importation of parasites by cross-border travelers from neighboring countries with higher rates of malaria infection.
This webinar aims to address the role of E8 malaria border posts and the need for improved surveillance to reduce cross border transmission across the E8 region.
Presentations:
1. Access to malaria prevention, diagnosis and treatment in border areas of E8 countries: results from an evaluation of malaria border posts in second line countries (Prof Immo Kleinschmidt, Mukosha Chisenga)
2. Plasmodium genomics as a surveillance tool for monitoring local malaria transmission networks and importation in Northern Namibia (Prof Davis Mumbengegwi)
3. Antimalarial Drug Resistance Surveillance, Primaquine and E8 malaria border posts in South Africa (Dr Jaishree Raman)
Register in advance for this webinar:
https://us02web.zoom.us/webinar/register/WN_-s-Q3zMfQGOOE-FjGUvMbQ
The Stop
TB Partnership Working Group on New TB Vaccines (WGNV) and the National
Institute for Allergy and Infectious Diseases (NIAID)are
co-hosting a workshop on the topic of Recognition and Control of Mtb
Infected Cells: From Basics to the Clinic. This workshop is intended to address
the need for correlates and to identify platforms that measure recognition or
control of the infected cell - especially in humans - as identified in the EDCTP/AIGHD Global Roadmap for
Research and Development of New TB Vaccines and the Strategic Framework for
New TB Vaccines in the Stop TB Partnership Global Plan to End TB 2023 - 2030.
The overall goals of this workshop
are to:
The workshop format will be largely
discussion-based. Each session will have three short presentations that will
provide a high-level overview of key topics within the session theme, followed
by a discussion between the session chairs, speakers, and participants.
Click here
to view the programme and
speakers.
This workshop is free of charge and
open to any participants interested in this topic.
The International Society for Infectious Diseases (ISID) and the Swiss
Society for Infectious Diseases (SSI) are inviting applications for their joint
Infectious Diseases Research Fellowship Program. The purpose of this programme
is to support infectious disease physicians and scientists from under-resourced
countries through multidisciplinary clinical and laboratory training at a
select biomedical institution in Zurich, Switzerland. The one-year SSI/ISID
Fellowship programme is open to applicants who are 40 years or younger,
citizens and permanent residents of under-resourced countries or Eastern
Europe. The deadline for applications is 16 June 2023.
More information: https://na.eventscloud.com/eSites/748378/Homepage
The MRCT Center and Medable convened a multi-stakeholder task force to address ethical and regulatory opportunities and challenges related to Decentralized Clinical Trials (DCTs). Join them on June 20, from 10 - 11 AM ET, for a joint webinar entitled, "Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices."
During the webinar, Barbara Bierer (MRCT Center), Pam Tenaerts
(Medable) and Leanne Madre (Medable) will present a framework, recommendations,
and tools organized around 3 DCT domains: People, Remote Data Collection, and
Data Oversight. Best practices for the ethical review, approval, and conduct of
DCTs will be provided.
Clinical trial stakeholders (IRB/ECs,
HRPP, sites, sponsors, investigators, and others) to register for the webinar here